Please assess the completion status of the following clinical trial:

Trial Title: COVID-19 Vaccination in Rheumatic Disease Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Rheumatologist confirmed diagnosis of one of the following diagnoses:~* Systemic lupus erythematosus;~* Sjogren syndrome;~* Inflammatory myositis;~* Psoriatic arthritis;~* Osteoarthritis;~* Gout;~* Ankylosing spondylitis;~* IBD-related arthritis.~Exclusion Criteria:~* Active infection or untreated malignancy (other than skin cancer) at enrollment.~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- mRNA COVID19 vaccines (Type: OTHER): mRNA-based COVID19 vaccines

Based on this trial design, predict the completion outcome and termination type (if applicable).